News Lilly’s Verzenio joins breast cancer market The FDA has approved Lilly’s Verzenio, making it the third market entrant in a new class of drugs for breast cancer.
News More data supports Jardiance lead in cardiovascular battle Cardioprotective effect occurred in patients independently of blood sugar control
News Novo's semaglutide outperforms Lilly GLP-1 rival If approved semaglutide could become set the standard for GLP-1 therapy
News RA pill setback spoils Lilly’s growth story Eli Lilly has posted a strong 8% increase in sales for the second quarter, led by grow
News Surge of Alzheimer's drugs in pipeline gives hope of progres... Authors "optimistic" despite issues with front runners from AB Science and Otsuka
News J&J's psoriasis drug faces crowded market after US approval J&J taking on next gen drugs from Novartis, Eli Lilly, and Valeant.
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
